SubHero Banner

This is a phase 3 study to evaluate the effect of Efpeglenatide on cardiovascular outcomes in type 2 diabetes patients at high cardiovascular risk.

Participating locations

1919 State St.
Ste. 440
New Albany, IN 47150

Visit for more information.

For more information about clinical trials, please call us at 1-317-718-5482 or 1-877-340-7291.